Starch Grain Quinoa (Chenopodium quinoa Willd.): Composition, Morphology and Physico-Chemical Properties

Introduction. The main component of quinoa grain is starch, the properties of which affect the quality of quinoa-based food products. There is no information about quinoa starch in the Russian scientific literature. Therefore, the review summarizes and presents foreign knowledge about the isolation, chemical composition, structure, and physicochemical properties of quinoa starch Study objects and methods. The research featured scientific articles and chapters of scientific books on the structure and chemical composition of quinoa published over the past 10 years. The work used empirical and theoretical methods of scientific research. Results and its discussion. Currently, starch from quinoa grain is produced only under laboratory conditions by various methods of grinding and soaking. Most studies point to up to 10% of amylose in quinoa starch. Amylopectin in quinoa starch has a high number of short single chains and a very low number of long single chains, and their ratio is higher than that in other starches. The granule size of quinoa starch is 0.4–2.0 microns, which is significantly smaller than that of most starches. Quinoa starch belongs to polymorphic type A. The gelatinization temperature and enthalpy of quinoa starch are lower than those of amaranth, corn, sorghum, millet, and wheat starch, which is probably due to the fine structure of amylopectin. With an increase in temperature for every 10°C, the swelling force and solubility of quinoa starch increase on average by 21.5–27%. As the temperature rises from 55 to 65°C, the solubility index of quinoa starch increases sharply by 5–10 times. The viscosity of quinoa starch is significantly higher than that of most known starches. It also is more sensitive to enzymes. Conclusion. The work presents the results of scientific research on various matters: methods of starch isolation from quinoa, its chemical composition, and methods of amylose determination; structure of starch grains, their shape, type, and degree of crystallization; physicochemical properties of starch, including gelatinization, swelling, solubility, rheological properties, retrogradation, changes in the transparency of starch gel, and susceptibility to enzymes. The latter determines the choice of technological parameters in the development of formulations and food technologies, including functional foods for people with gluten intolerance (celiac disease). Further studies of the chemical composition of quinoa can help to meet the growing demand for these products and expand the range of the domestic market for gluten-free foods.

Post-Transplant Lymphoproliferative Disorder after Renal Transplant in the Pediatric Population: A Systematic Review

Background: Post-transplant lymphoproliferative disease (PTLD), is one of the major complications after organ transplantation. The aim of this study is to study the incidence, various risk factors especially EBV status, histopathological types, management, and outcomes of PTLD following kidney transplantation in the pediatric groups. Methods: Following the PRISMA guideline, we performed a comprehensive literature search on PubMed, Cochrane Library, Embase, and clinicaltrials.gov from the past ten years on May 04, 2020. We used the MeSH terms of organ transplantation and lymphoproliferative disorders. The initial search revealed 1741 articles. We excluded all case reports, case series, pre-clinical trials, review articles, and meta-analysis. We found five retrospectives observational, one retrospective questionnaire survey, one prospective observational, and one prospective trial study. We extracted the data for baseline characteristics, the reason for transplantation, recipient & donor EBV status, immunosuppression used, type & stage of PTLD, organ system involved, duration between transplant and PTLD diagnosis, treatment, response to therapy, adverse effects of therapy and mortality. Results: We included eight studies with a total (n) number of 1713 post-kidney transplant pediatric patients, out of which 148 (8.63%) patients who developed PTLD as a complication of transplantation were studied(table 1). Among the 148 patients diagnosed with PTLD, 96 (64.86%) were males, 49 (33.1%) female participants and 3 (2.2%) were unknown. 34/148 (22.97%) PTLD recipients were EBV (+), 86 (58.1%) EBV (-) and 28 (18.9%) unknown at the time of transplant. EBV status for donors was known in only 2 studies, showing 7/99 (7.1%) to be EBV (+) at the time of transplant. Höcker et al. have shown that antiviral prophylaxis with ganciclovir/valganciclovir in the first year post-renal transplant reduces the risk of EBV viremia. Post-transplant immunosuppressive drugs included tacrolimus, mycophenolate mofetil, azathioprine, sirolimus, cyclosporine, IL-2R antagonist, methylprednisolone, basiliximab, daclizumab, anti-thymocyte globulin/anti-lymphocyte globulin, OKT3. In some cohorts, rituximab and antiviral prophylaxis with ganciclovir or valganciclovir were also used in some patients. The median time from transplant to the diagnosis of PTLD from five studies with 125 patients was 16 months (0.9m-186m). Longmore et al. reported a bimodal distribution curve, with 50% presenting with early PTLD, i.e. after a median duration of 313 days and 50% presenting late after a median duration of 8 years. The histopathological types of PTLD were diagnosed via biopsy samples, showing predominance with polymorphic type 48 (32.4%), followed by monomorphic type 45 (30.4%), early lesion 4 (2.7%), Kaposi like PTLD 1 (0.67%) and Hodgkin lymphoma 1 (0.67%). The histological testing results from two of the studies also showed that 18/19 (94.7%) of diagnosed PTLD samples were EBV positive. PTLD was managed with reduction or cessation of the immunosuppressive drugs, anti-CD20 antibodies, chemotherapy for lymphoma, and in some cases mTOR inhibitors, intravenous immunoglobulins, and surgical resection. Data from 5 studies show the mortality rate of 12/51 (23.5%) among PTLD groups. The survival rate from 2 studies was 100% among 17 PTLD patients and 1 study showed a 5-year survival rate of 85% among 92 PTLD patients. Cleper et al. in their study concluded that the type of PTLD might have a significant effect on the outcome, as ¾ (75%) deaths in the PTLD group were attributed to anaplastic T-cell type. Conclusions: Our analysis shows the EBV infection is closely associated with a higher risk of PTLD development. Recipients' EBV seronegativity and positive EBV status of the donor have been shown to increase post-transplant EBV infection risk which is associated with a higher risk of PTLD development. Furthermore, our study shows that PTLD may occur in less than a month to more than 15 years of renal transplant. The polymorphic type was the most common and Hodgkin lymphoma-type, the least commonly reported PTLD type. The main therapeutic approach is the reduction or cessation of immunosuppression. Disclosures Anwer: Incyte, Seattle Genetics, Acetylon Pharmaceuticals, AbbVie Pharma, Astellas Pharma, Celegene, Millennium Pharmaceuticals.: Honoraria, Research Funding, Speakers Bureau.

Polymorphic+Typeclass Superposition

We present an extension of superposition that natively handles a polymorphic type system extended with type classes, thus eliminating the need for type encodings when used by an interactive theorem prover like Isabelle/HOL. We describe syntax, typing rules, semantics, the polymorphic superposition calculus and an evaluation on a problem set that is generated from Isabelle/HOL theories. Our evaluation shows that native polymorphic+typeclass performance compares favorably to monomorphisation, a highly efficient but incomplete way of dealing with polymorphism.

No value restriction is needed for algebraic effects and handlers

We present a straightforward, sound, Hindley–Milner polymorphic type system for algebraic effects and handlers in a call-by-value calculus, which, to our surprise, allows type variable generalisation of arbitrary computations, and not just values. We first recall that the soundness of unrestricted call-by-value Hindley–Milner polymorphism is known to fail in the presence of computational effects such as reference cells and continuations, and that many programming examples can be recast to use effect handlers instead of these effects. After presenting the calculus and its soundness proof, formalised in Twelf, we analyse the expressive power of effect handlers with respect to state effects. We conjecture handlers alone cannot express reference cells, but show they can simulate dynamically scoped state, establishing that dynamic binding also does not need a value restriction.

Correctness of compiling polymorphism to dynamic typing

The connection between polymorphic and dynamic typing was originally considered by Curry et al. (1972, Combinatory Logic, vol. ii) in the form of “polymorphic type assignment” for untyped λ-terms. Types are assigned after the fact to what is, in modern terminology, a dynamic language. Interest in type assignment was revitalized by the proposals of Bracha et al. (1998, OOPSLA) and Bank et al. (1997, POPL) to enrich Java with polymorphism (generics), which in turn sparked the development of other languages, such as Scala, with similar combinations of features. In such a setting, where the target language already has a monomorphic type system, it is desirable to compile polymorphism to dynamic typing in such a way that as much static typing as possible is preserved, relying on dynamics only insofar as genericity is actually required. The basic approach is to compile polymorphism using embeddings from each type into a universal “top” type, ${\mathbb{D}}$, and partial projections that go in the other direction. This scheme is intuitively reasonable, and, indeed, has been used in practice many times. Proving its correctness, however, is non-trivial. This paper studies the compilation of System F to an extension of Moggi's computational meta-language with a dynamic type and shows how the compilation may be proved correct using a logical relation.

Cytological variations and typical diagnostic features of endocervical adenocarcinoma in situ: A retrospective study of 74 cases

Background: The sensitivity of Papanicolaou smears for detecting endocervical adenocarcinoma in situ (AIS) is very low. A comprehensive cytological analysis of endocervical AIS is necessary to increase diagnostic accuracy. Methods: The subjects were 74 patients with pathologically-diagnosed AIS. A total of 140 Papanicolaou smears were reviewed to calculate the sensitivity of the Papanicolaou smears for detecting AIS and the incidence of sampling/screening/diagnostic errors. The cytological review was performed by 6 cytotechnologists, and the final cytological diagnosis was obtained at the consensus meeting. We classified the cases into three differentiation types; typical type (well-differentiated AIS), polymorphic type (poorly differentiated AIS), and mixed typical and polymorphic type. Three cytological subtypes (endocervical, endometrioid and intestinal subtypes) of AIS were also analyzed. Results: The sensitivity of the original Papanicolaou smears for the detection of AIS was 44.6%, while that for the detection of AIS and adenocarcinoma was 63.5%. The diagnostic accuracy of AIS increased to 78.5% in the final diagnosis. The common characteristic features were microbiopsies/hyperchromatic crowded groups (HCG) (82.0%) and mitotic figures (72.2%). The appearance of single cells (2.8%) was rare, and all the cervical cytology smears showed no evidence of necrotic tumor diathesis. The most common AIS was the typical type (41 cases, 67.2%) among all cytologically-diagnosed AIS or adenocarcinoma cases (61 cases). Although mixed typical and polymorphic AIS existed in 17 cases (27.9%), pure polymorphic AIS was very rare (3 cases, 4.9%). The endocervical subtype was the most predominant subtype (67.2%), followed by a few mixed subtypes. The important diagnostic keys for AIS cytology are as follows: (1) The appearance of microbiopsies/HCG (single-cell pattern is rare), (2) mitotic figures in the microbiopsies/HCG, (3) a lack of necrotic tumor diathesis in cases with polymorphic AIS, and (4) recognition of typical cytological subtypes. Conclusions: The relatively low diagnostic accuracy AIS was caused by the underestimation of microbiopsies/HCG and the overestimation of polymorphic components. The typical cytological features of AIS are the presence of microbiopsies/HCG with mitotic figures in the absence of necrotic tumor diathesis in specimens containing endocervical samples. The recognition of infrequent AIS subtypes (endometrioid and intestinal subtypes) is also important.